Archives
-
From Barrier Biology to Faster Genotyping
2026-09-21
A translational strategy for connecting epithelial-barrier mechanisms with faster, contamination-conscious genotyping workflows across tissues, insects, fishes, and cells.
-
Direct Mouse Genotyping Kit Plus: Assay Logic
2026-09-20
The Direct Mouse Genotyping Kit Plus connects rapid direct PCR with phenotype-focused study design. Learn how genotype quality, controls, and model confirmation strengthen neurodegeneration research inspired by recent SCA3 mouse findings.
-
CXCL12 in Brucella Host–Pathogen Translation
2026-09-19
A translational framework for using SDF-1beta (CXCL12), human recombinant as a defined perturbation tool alongside host-gene discovery in Brucella macrophage models. The article connects genome-wide screening, mechanistic validation, experimental design, and responsible interpretation without overstating evidence that has not yet been generated.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-09-18
A 2024 PLOS Pathogens study identifies Lactobacillus gasseri ATCC33323 as a protective intervention in DSS-induced colitis and links its activity to intestinal E-cadherin. The work combines barrier-function measurements, intestinal E-cadherin loss-of-function experiments, transcriptional analysis, and in vitro validation to propose an NR1I3–CDH1 regulatory pathway.
-
Guanabenz Acetate: α2-Adrenergic Signaling
2026-09-18
Guanabenz Acetate is an α2-adrenergic receptor agonist with reported activity at α2a, α2b, and α2c subtypes. Its defined potency profile and DMSO solubility support controlled GPCR signaling and neuroscience receptor research, but current SARS-CoV-2 evidence does not establish an antiviral effect for this compound.
-
STMN2 Depletion, Translation Deficits, and ALS Stress
2026-09-17
The reference study identifies TDP-43-independent mechanisms that rapidly deplete STMN2 during neuronal stress, linking proteasomal degradation, phosphorylation, stress-granule-associated translation repression, and chronic translation deficits. Its findings suggest that STMN2 abundance is both a stress-sensitive determinant of neuronal survival and a context-dependent readout of compensatory RNA responses in ALS.
-
YAP–TEAD Super-Enhancers in Ectoderm Commitment
2026-09-17
Wang and colleagues map how super-enhancer architecture and YAP–TEAD activity coordinate early surface ectoderm commitment from pluripotent stem cells. By combining three-dimensional genomic profiling with CRISPR-dCas9 perturbation and transcription-factor network analysis, the study connects enhancer activity to lineage progression and provides a mechanistic framework for epithelial regeneration research.
-
Genotyping Kit: From Sample to Mechanism
2026-09-16
The Genotyping Kit for target alleles supports rapid PCR amplification of genomic DNA from diverse biological samples. This article connects single-tube DNA extraction with mechanism-focused assay design, using intestinal barrier research to clarify what genotyping can—and cannot—prove.
-
KU-55933: ATM Kinase Inhibitor Workflow Guide
2026-09-16
KU-55933 enables selective interrogation of ATM signaling across DNA damage response, phospho-Akt, cell-cycle, and metabolic assays. This practical guide connects compound handling with the ClpP–mitochondrial stress findings reported in lung squamous cell carcinoma research while clearly separating established evidence from proposed assay extensions.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-15
Use dual fluorescence to separate mRNA uptake from productive translation in one experiment. This workflow shows how to apply the reporter to LNP validation, macrophage delivery studies, and quantitative transfection optimization while avoiding common interpretation errors.
-
MCC950 sodium for NLRP3 Research Workflows
2026-09-15
MCC950 sodium enables selective dissection of NLRP3-driven IL-1β biology across macrophage, neuroinflammation, and autoimmune disease workflows. This practical guide connects concentration planning, cytokine controls, astrocyte phenotyping, and in vivo study design while highlighting limitations that can compromise interpretation.
-
SMYD2, miR-125b, and Drug Resistance in RCC
2026-09-14
The reference study identifies SMYD2 as a prognostic and functional driver of clear cell renal cell carcinoma, linking epigenetic regulation to miR-125b, DKK3, and P-glycoprotein-mediated multidrug resistance. Its combined patient-cohort, molecular, cellular, and xenograft design provides a useful framework for testing whether SMYD2 inhibition can improve responses to established anticancer drugs.
-
SARS-CoV-2 Nucleocapsid and GADD34 Stress Foci
2026-09-14
The reference study identifies a mechanism in which SARS-CoV-2 nucleocapsid protein redirects GADD34 mRNA into atypical N+/G3BP1+ foci, weakening IRF3-dependent interferon signaling. Its findings refine the antiviral role of stress granule biology and provide a framework for testing how viral condensates suppress innate immunity.
-
Hydrocortisone for Controlled Corticosteroid Delivery
2026-09-13
Hydrocortisone provides a practical glucocorticoid benchmark for inflammation, barrier, neuroprotection, and controlled-release studies. This guide connects solution-based assays with PLGA microsphere design, emphasizing stability, tissue penetration, and troubleshooting decisions that improve translational relevance.
-
Schizophrenia Risk Pathways in Developing Neurons
2026-09-12
Liu et al. show that schizophrenia-associated GWAS loci converge on different biological pathways in developing cortical interneurons and glutamatergic neurons. Their combination of cell-type-resolved transcriptomics, chromatin profiling, morphology, transplantation, and electrophysiology links interneuron risk biology to PKC signaling and glutamatergic-neuron risk biology to ion transport.